PISANI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 4.977
EU - Europa 1.357
AS - Asia 165
AF - Africa 15
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.521
Nazione #
US - Stati Uniti d'America 4.962
IE - Irlanda 1.100
CN - Cina 130
IT - Italia 84
FI - Finlandia 61
BE - Belgio 37
DE - Germania 25
IN - India 22
CA - Canada 15
MU - Mauritius 14
SE - Svezia 14
RU - Federazione Russa 13
FR - Francia 9
GB - Regno Unito 5
CO - Colombia 4
IR - Iran 4
AU - Australia 2
ES - Italia 2
GR - Grecia 2
MY - Malesia 2
NL - Olanda 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
JP - Giappone 1
NP - Nepal 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 6.521
Città #
Chandler 1.531
Dublin 1.096
Ashburn 551
Princeton 297
Lawrence 288
Wilmington 282
Medford 178
Fairfield 101
Ann Arbor 90
Falls Church 66
Norwalk 58
Helsinki 57
Washington 55
Seattle 49
Woodbridge 47
Shanghai 45
Los Angeles 42
Brussels 37
Beijing 23
Nanjing 19
Pune 19
New York 13
Toronto 12
Rome 11
Pavia 8
Jacksonville 7
Nanchang 7
Napoli 7
Hangzhou 6
Changsha 5
Palermo 5
Shenyang 5
Hebei 4
Houston 4
Jinan 4
Manerbio 4
Detroit 3
Jiaxing 3
Legnano 3
Matino 3
Pontoglio 3
Tianjin 3
Zhengzhou 3
Azzano San Paolo 2
Barnsley 2
Bengaluru 2
Davoli 2
Edmonton 2
Eindhoven 2
Madrid 2
Medellín 2
Nardò 2
Redmond 2
Redwood City 2
San Francisco 2
Seregno 2
Sulmona 2
West Jordan 2
Zanjan 2
Acireale 1
Andover 1
Atlanta 1
Bari 1
Bergamo 1
Bratislava 1
Bucharest 1
Cambridge 1
Canberra 1
Cheboksary 1
Clearwater 1
Des Moines 1
Esfahan 1
Frankfurt am Main 1
Galway 1
Huskvarna 1
Leawood 1
London 1
Lyon 1
Melbourne 1
Milan 1
Monmouth Junction 1
Ningbo 1
Nishinotoindori 1
Nuremberg 1
Phetchabun 1
Philadelphia 1
Phoenix 1
Riyadh 1
Rognano 1
San Nicola la Strada 1
Santa Clara 1
Shijiazhuang 1
Tashkent 1
Vancouver 1
Totale 5.121
Nome #
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 42
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission 42
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 41
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 40
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 40
Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia 39
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 39
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 37
Hypoxia-induced electrical changes in striatal neurons 37
Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID-19 Lockdown 37
Corticostriatal synaptic plasticity in PINK1 heterozygous mice: Effects of mitochondrial complex I inhibition 36
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 36
Dystonia as a network disorder: A concept in evolution 36
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 36
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 35
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 35
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 35
Acetylcholine-mediated modulation of striatal function 35
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 35
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 35
Mild mitochondrial impairment promotes corticostriatal synaptic plasticity alterations in PINK1 heterozygous knockout mice 34
Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia 34
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 34
The neuroligins and the synaptic pathway in Autism Spectrum Disorder 33
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 33
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 33
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 33
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 33
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 33
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 33
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia 33
The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection 32
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice 32
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 32
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum 32
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 31
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 31
Synaptic transmission in the striatum: from plasticity to neurodegeneration 31
Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum 31
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons 31
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia 31
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 31
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 31
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 31
Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons 31
Long-term treatment with rotigotine in drug-naïve PSP patients 31
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 31
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 30
Tissue plasminogen activator is required for corticostriatal long-term potentiation 30
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report 30
Models of dystonia: an update 30
Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia 30
Group 1 mGluR responses in distinct striatal interneuron subtypes 29
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 29
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 29
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia 29
Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients 29
Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones 29
Lithium treatment blocks long-term synaptic depression in the striatum 29
The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum 29
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 29
Metabotropic glutamate receptors and neuronal toxicity 28
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 28
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect 28
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 28
Dopaminergic involvement in a drummer with focal dystonia: A case study 28
Generation of a novel rodent model for DYT1 dystonia 28
Double hit mouse model of Parkinson's disease 28
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 28
Muscarinic IPSPs in rat striatal cholinergic interneurones 28
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia 28
Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons 28
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 28
L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons 28
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology 28
Facemasks and face recognition: Potential impact on synaptic plasticity 28
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 28
A2a receptor dysregulation in dystonia dyt1 knock-out mice 28
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 27
Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons 27
Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition 27
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment 27
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 27
Heterogeneity of metabotropic glutamate receptors in the striatum: electrophysiological evidence 27
Outward potassium currents activated by depolarization in rat globus pallidus 27
Loss of non-apoptotic role of caspase-3 in the PINK1 mouse model of Parkinson’s disease 27
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 27
Dystonia 26
Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson's Disease 26
Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission 26
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 26
Post-receptor mechanisms underlying striatal long-term depression 26
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 26
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 26
Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission 26
Does SARS-Cov-2 invade the brain? Translational lessons from animal models 26
Presynaptic modulation by group III metabotropic glutamate receptors (mGluRs) of the excitatory postsynaptic potential mediated by mGluR1 in rat cerebellar Purkinje cells 26
Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia 26
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 26
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 26
Totale 3.082
Categoria #
all - tutte 40.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/202050 20 26 0 0 0 0 0 0 0 3 1 0
2020/2021623 0 0 0 0 286 7 4 258 6 7 31 24
2021/20221.152 21 5 9 11 32 47 42 100 91 18 162 614
2022/20233.635 367 170 63 396 289 461 11 264 1.425 27 95 67
2023/20241.378 152 227 84 101 159 449 64 70 10 58 4 0
Totale 6.860